Grant Details

GRANT OVERVIEW

Grant Name and Funding Organization

Clinical and Translational Science Award (UM1 Clinical Trial Optional)

National Institutes of Health (NIH)

Total Funding Amount and Duration

Maximum project period of 7 years

No specified funding ceiling

Primary Objective and Mission Statement

To advance clinical and translational science through collaborative research hubs

To improve the efficiency and effectiveness of clinical translation

To promote partnerships and collaborations in translational research

Key Stakeholders and Beneficiaries

Medical research institutions

Academic health centers

Community health organizations

Patients and communities affected by health disparities

ELIGIBILITY CRITERIA

Organization Requirements

Eligible organization types include higher education institutions, nonprofits, for-profit organizations, local and state governments, and tribal governments.

Organizations with active grants under specific NOFOs are not eligible to apply.

Geographic Scope

U.S. based organizations are eligible.

Non-domestic (non-U.S.) entities are not eligible to apply.

Project Requirements

Focus on clinical and translational science.

Projects must address significant challenges in translational research.

Financial Requirements

Direct costs for the CTS Research Program must not exceed $500,000 per year.

Pilot projects must be between $25,000 and $50,000 in direct costs.

Timeline Requirements

Applications are due by 5:00 PM local time on specified due dates.

The maximum project period is 7 years.

Previous Funding Considerations

Organizations named as Partner Institutions in a funded CTSA UM1 or UL1 award may not apply unless under specific circumstances.

APPLICATION PROCESS

Required Documentation and Materials

Applications must include specific elements and modules as outlined in the application guide.

Letters of support from partnering institutions are required.

Evaluation Criteria and Scoring System

Applications will be evaluated based on significance, investigator(s), innovation, approach, and environment.

Review Process and Timeline

Applications will undergo peer review and receive a written critique.

Funding decisions will be based on scientific merit and programmatic priorities.

Selection Criteria and Priorities

Applications must demonstrate a collaborative approach and address health disparities.

SPECIAL CONSIDERATIONS

Unique Aspects or Requirements

The program emphasizes collaboration among various disciplines and institutions.

Potential Challenges or Limitations

Organizations with overlapping applications may face restrictions.

Strategic Alignment Opportunities

Encouragement of partnerships across different sectors and disciplines.

Competitive Advantages or Disadvantages

Strong institutional commitment and collaboration can enhance competitiveness.

KEY INSIGHTS AND RECOMMENDATIONS

Critical Success Factors

Demonstrated expertise and capabilities in clinical and translational science.

Common Pitfalls to Avoid

Failure to comply with application instructions may lead to rejection.

Strategic Recommendations for Applicants

Engage with stakeholders early in the application process.

Competitive Positioning Advice

Highlight unique strengths and collaborative capabilities in the application.

Grant Details

clinical research translational science health disparities collaborative research medical research public health NIH funding healthcare innovation
Clinical and Translational Science Award (UM1 Clinical Trial Optional)
PAR-24-272
Clinical and Translational Science Award (CTSA)
UNIVERSITY NGO PUBLIC ENTERPRISE OTHER
US
RESEARCH_DEVELOPMENT CAPACITY_BUILDING
False
None
None
None
USD
None
True
True
The program aims to improve the efficiency and effectiveness of clinical translation, ultimately benefiting public health.
Successful applications will result in the establishment of CTSA hubs that facilitate collaborative research and training.
Sept. 28, 2027, 9 p.m.
March 2025 - September 2027
Application forms, letters of support, budget justification, and compliance documentation.
True
Peer review with scoring based on significance, innovation, approach, and environment.
Projects must demonstrate innovative approaches to clinical and translational science.
Proposals must be feasible within the proposed timeframe and budget.
Applications should demonstrate potential for significant impact on public health.
True
True
Cooperative Agreement
Recipients must comply with NIH policies and demonstrate effective collaboration.
Annual progress reports and financial statements are required.
Payments will be made based on the approved budget and progress reports.
All NIH grants are subject to federal regulations and NIH Grants Policy Statement.
No additional sector-specific requirements are noted.